Microglial Advances in Neurodegenerative Diseases
- 1st Edition, Volume 171 - September 1, 2026
- Latest edition
- Editor: Subashchandrabose Chinnathambi
- Language: English
Microglial Advances in Neurodegenerative Diseases, Volume 170 in the Advances in Immunology series, presents current developments and comprehensive reviews focused on the role of m… Read more
Description
Description
Microglial Advances in Neurodegenerative Diseases, Volume 170 in the Advances in Immunology series, presents current developments and comprehensive reviews focused on the role of microglia and neuroinflammation in neurological and psychiatric disorders. This volume brings together contributions from leading researchers, offering up-to-date insights into microglial biology in health and disease, as well as their involvement in major neurodegenerative conditions. Chapters in this new release explore Cross-talk between Tau and Neuro-glia Axis of Alzheimer’s Disease, Microglia in Health and Disease, Amyloid-beta (Aβ) and Neuroinflammation in Microglia, Chemokine Receptor CX3CR1 Interacts with Tau and Regulates Microglial Activity in Alzheimer’s Disease, and much more.
Additional chapters explore Human-Induced Pluripotent Stem Cells in Psychiatric Disorders, GPCR-Mediated Internalization and Endosomal Sorting of the Tau–GPCR Complex in Microglia, iPSC-Derived Microglia: A Cellular Platform for Tau and Alzheimer’s Disease Immunotherapy, Advancements in Invasive and Non-Invasive Neuromodulation for Parkinson’s Disease, LRRK2-I1371V Disrupts Microglial Membrane Homeostasis and Enhances α-Synuclein Toxicity, Microglial Advances in Parkinson’s Disease, Microglial Advances in Alzheimer’s Disease, and more.
Key features
Key features
- Presents current advances and authoritative reviews on microglial biology and neuroinflammation
- Includes contributions from leading international experts in neuroscience and neurodegenerative research
- Covers microglial roles in Alzheimer’s disease, Parkinson’s disease, ALS, and psychiatric disorders
- Highlights emerging cellular models, including iPSC-derived microglia and novel therapeutic approaches
- Serves as an essential reference for researchers, clinicians, and graduate students in neuroscience and neuroimmunology
Readership
Readership
Table of contents
Table of contents
1. Cross-talk between Tau and Neuro-glia Axis of Alzheimer’s Disease
2. Microglia in Health and Disease
3. Amyloid-beta (Aβ) and Neuroinflammation in Microglia
4. Chemokine Receptor CX3CR1 Interacts with Tau and Regulates Microglial Activity in Alzheimer’s Disease
5. Human-Induced Pluripotent Stem Cells in Psychiatric Disorders
6. GPCR-Mediated Internalization and Endosomal Sorting of the Tau–GPCR Complex in Microglia
7. iPSC-Derived Microglia: A Cellular Platform for Tau and Alzheimer’s Disease Immunotherapy
8. Advancements in Invasive and Non-Invasive Neuromodulation for Parkinson’s Disease
9. LRRK2-I1371V Disrupts Microglial Membrane Homeostasis and Enhances α-Synuclein Toxicity
10. Microglial Advances in Parkinson’s Disease
11. Microglial Advances in Alzheimer’s Disease
12. iPSC-Derived Microglial Advances in Amyotrophic Lateral Sclerosis (ALS)
13. Glial Advances in Neurodegenerative Diseases
14. Microglial Dynamics and Neuroinflammation in the Early Onset of Parkinson’s Disease
15. Microglial Advances in Psychiatric Disorders
16. Astroglial Advances in Neurodegenerative Diseases
17. Neuroinflammation in Parkinson’s Disease
Product details
Product details
- Edition: 1
- Latest edition
- Volume: 171
- Published: September 1, 2026
- Language: English
About the editor
About the editor
SC
Subashchandrabose Chinnathambi
Subashchandrabose Chinnathambi is Additional Professor at the Department of Neurochemistry, National Institute of Mental Health and Neurosciences Hospital Bangalore, Karnataka, India. His scientific interests include physiopathology of neurodegenerative disorders, Tau Cytoskeleton, Tau-GPCR, purinergic and chemokine receptors, Tau stem cells, animal models, neuropharmacology, therapeutic approaches targeting Tau oligomers, and biomarkers for neurodegeneration. He serves on the editorial board for various international cell biology journals and is also a regular invited speaker at a number of meetings and workshops. Dr. Chinnathambi has more than 16 years of research experience in the area of neuroscience and Tau-related research in Alzheimer’s Disease.